Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP005 in Actinic Keratosis
NCT00107965Phase 2Completed
- Sponsor
- Peplin
- Start
- Mar 2005
- Primary completion
- Sep 2005
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Peplin. Started Mar 2005; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00107965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107965.